At a glance
ClinicalIndex Comparison RecordN/ACompleted· 57 enrolled
Drug / intervention
Supine MRI +5 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
In Brief
A clinical study evaluating Supine MRI, Neoadjuvant Therapy (NAT), and 4 other interventions for Breast Cancer. Completed, enrolled 57 participants across 2 sites.
Detailed Summary
This research study involves the use of a common breast imaging modality (magnetic resonance imaging, 'MRI') and is investigating its role in evaluating surgical decision making for breast cancer when it is performed with the patient in a new position (lying on one's back) as opposed to in the standard position (lying on one's stomach).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartNov 2016
Primary CompletionAug 2022
TodayJul 2026
First PostedNov 7, 2016
Enrollment StartNov 15, 2016
Primary CompletionAug 1, 2022
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 9.7 years ago
Interventions
Supine MRIdevice
Neoadjuvant Therapy (NAT)other
Ultrasounddevice
Mammographydevice
Standard of Careprocedure
Standard MRIdevice